Extent of oxidative modification of low density lipoprotein determines the degree of cytotoxicity to human coronary artery cells.

S. A. Thorne, S. E. Abbot, P. G. Winyard, D. R. Blake, P. G. Mills

Cardiac Department, Royal London Hospital.

OBJECTIVE--To assess whether the extent of LDL oxidation influences its cytotoxic effects, thus contributing to its atherogenic potential. DESIGN AND SETTING--The effects of native and modified LDL on cultured human coronary artery smooth muscle cells (SMC) and endothelial cells (ECs) were investigated. MAIN OUTCOME MEASURES--Four indices of cytotoxicity were studied: (i) chromium-51 release; (ii) 5-bromo-2'-deoxyuridine (BrDUrd) uptake; (iii) morphological appearance; and (iv) EC migration. RESULTS--(i) Minimally modified (mm) LDL (400 micrograms/ml) causes significant 51Cr release; the cytotoxic effect was significantly greater for copper oxidised (ox) LDL (400 micrograms/ml). Native LDL had no effect. (ii) BrDUrd uptake studies showed significant inhibition of cell proliferation by 100 micrograms/ml of oxLDL and to a lesser extent by mmLDL; native LDL had no effect. (iii) Morphological appearance was not altered by native LDL. Changes in cell morphology were induced by mmLDL (400 micrograms/ml), and were more pronounced with oxLDL in concentrations of > or = 200 micrograms/ml. (iv) EC migration was significantly inhibited by oxLDL (100 micrograms/ml), but not by native or mmLDL. CONCLUSION--The extent of oxidation of LDL determined its cytotoxicity to coronary artery cells. Native LDL had no cytotoxic effect. In contrast, oxLDL and to a lesser extent mmLDL caused cytotoxicity at concentrations to which cells in vivo might be exposed. This may contribute to the atherogenicity of modified LDL by enhancing cellular injury and inflammation, and by inhibiting re-endothelialisation of areas of coronary artery damaged during the atherogenic process.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Marketou, M. E., Zacharis, E. A., Nikitovic, D., Ganotakis, E. S., Parthenakis, F. I., Maliaraki, N., Vardas, P. E. (2006). Early Effects of Simvastatin versus Atorvastatin on Oxidative Stress and Proinflammatory Cytokines in Hyperlipidemic Subjects. ANGIOLOGY 57: 211-218 [Abstract]  
• Veiraiah, A. (2005). Hyperglycemia, Lipoprotein Glycation, and Vascular Disease. ANGIOLOGY 56: 431-438 [Abstract]  
• Kataoka, H., Kume, N., Miyamoto, S., Minami, M., Morimoto, M., Hayashida, K., Hashimoto, N., Kita, T. (2001). Oxidized LDL Modulates Bax/Bcl-2 Through the Lectinlike Ox-LDL Receptor-1 in Vascular Smooth Muscle Cells. Arterioscler. Thromb. Vasc. Bio. 21: 955-960 [Abstract] [Full Text]  
• Siow, R. C. M., Richards, J. P., Pedley, K. C., Leake, D. S., Mann, G. E. (1999). Vitamin C Protects Human Vascular Smooth Muscle Cells Against Apoptosis Induced by Moderately Oxidized LDL Containing High Levels of Lipid Hydroperoxides. Arterioscler. Thromb. Vasc. Bio. 19: 2387-2394 [Abstract] [Full Text]  
• Thorne, S., Mullen, M. J., Clarkson, P., Donald, A. E., Deanfield, J. E. (1998). Early endothelial dysfunction in adults at risk from atherosclerosis: different responses to L-arginine. J Am Coll Cardiol 32: 110-116 [Abstract] [Full Text]